Internal Server Error

Denovo Sciences - About the company

Denovo Sciences is a funded company based in Yerevan (Armenia), founded in 2019 by Vardan Harutunyan, Hovakim Zakaryan and Mher Matevosyan. It operates as an AI-enabled platform for drug discovery and development. The company has 286 active competitors, including 87 funded and 15 that have exited. Its top competitors include companies like Schrodinger, Relay Therapeutics and XtalPi.

Company Details

AI-enabled platform for drug discovery and development. The platform provides drug discovery and development solutions for novel therapeutics. The platform is currently targeting molecules for antiviral agents and cancer drugs.
Email ID
*****@denovosciences.ai
Phone Number
+374 **********
Key Metrics
Founded Year
2019
Location
Yerevan, Armenia
Stage
Funding Raised
Ranked
Employee Count
19 as on Sep 30, 2026
Similar Companies
Sign up to download Denovo Sciences' company profile

Denovo Sciences's funding and investors

Denovo Sciences is a funded company. Denovo Sciences has 4 institutional investors.

Denovo Sciences' founders and board of directors

Founder? Claim Profile
The founders of Denovo Sciences are Vardan Harutunyan, Hovakim Zakaryan and Mher Matevosyan.
Here are the details of Denovo Sciences' key team members:

Denovo Sciences' employee count trend

Denovo Sciences has 19 employees as of Sep 26. Here is Denovo Sciences's employee count trend over the years:
Employee count trend for Denovo Sciences
lockUncover Denovo Sciences' growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Denovo Sciences's Competitors and alternates

Top competitors of Denovo Sciences include Schrodinger, Relay Therapeutics and XtalPi. Here is the list of Top 10 competitors of Denovo Sciences, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Schrodinger
Schrodinger
1990, New York City (United States), Acquired
Provider of a web-based simulation and modelling tool
$162M
72/100
2nd
Logo for Relay Therapeutics
Relay Therapeutics
2016, Cambridge (United States), Public
Developer of drug discovery platform and study protein motion
$520M
69/100
3rd
Logo for XtalPi
XtalPi
2014, Cambridge (United States), Public
AI-based drug research and development company
$785M
69/100
4th
Logo for Valo Health
Valo Health
2019, Boston (United States), Series B
AI-powered platform for drug discovery and development
$450M
69/100
5th
Logo for Xaira
Xaira
2023, San Francisco (United States), Series D
AI-enabled platform for drug discovery and development
$1B
65/100
6th
Logo for Tandem AI
Tandem AI
2021, New York (United States), Series A
AI-based drug discovery tool for researchers
$82M
64/100
7th
Logo for Genesis Therapeutics
Genesis Therapeutics
2019, San Francisco (United States), Series B
Developer of an AI platform for discovering and designing novel drugs
$304M
64/100
8th
AI-enabled drug discovery and development platform for novel therapeutics
$452M
64/100
9th
Logo for Aqemia
Aqemia
2019, Paris (France), Series A
Provider of an AI and quantum physics to discover therapeutic molecules
$101M
63/100
10th
Logo for In Silico
In Silico
2014, Boston (United States), Public
AI-enabled bioinformatics platform for drug discovery and biomarker development
$510M
63/100
79th
Logo for Denovo Sciences
Denovo Sciences
2019, Yerevan (Armenia), Funding Raised
AI-enabled platform for drug discovery and development
-
35/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Denovo Sciences's competitors? Click here to see the top ones

Denovo Sciences's Investments and acquisitions

Denovo Sciences has made no investments or acquisitions yet.

Reports related to Denovo Sciences

Here is the latest report on Denovo Sciences's sector:

FAQs about Denovo Sciences

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford